Skip to content
★ Sign in to follow
NM

Norman Michael Greenberg

Atreca, Inc.
Total declarations
47
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (26 ops.)
€2.1M

Latest filing published 19 Mar 2021 for Atreca, Inc., €9,035.

Filing timeline

BuySale
Norman Michael Greenberg

Insider track record

Disclosed buys
0
Disclosed sells
26
Signal history

Norman Michael Greenberg: trading record in brief

This profile gathers the share dealings of Norman Michael Greenberg in Atreca, Inc. The record holds 47 filings, for trades running from 17 January 2020 to 17 March 2021.

The open-market record consists of 26 sales worth €2.1M, with no purchase. Besides market trades, the filings include 21 option exercises. Since January 2021: no purchases and 4 sales on the market.

On 19 March 2021 came the latest disclosure, an open-market sale for €29k in Atreca, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Norman Michael Greenberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations47 total
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    10,753 USD11SEC
    2,084 shares@ US$5.160.3% of flowClass A Common StockSEC:0001209191-21-022172:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    34,865 USD26SEC
    2,084 shares@ US$16.731.1% of flowClass A Common StockSEC:0001209191-21-022172:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    13,297 USD11SEC
    2,916 shares@ US$4.560.4% of flowClass A Common StockSEC:0001209191-21-022172:2
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    48,785 USD26SEC
    2,916 shares@ US$16.731.5% of flowClass A Common StockSEC:0001209191-21-022172:3
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    25,800 USD11SEC
    5,000 shares@ US$5.160.8% of flowClass A Common StockSEC:0001209191-21-012593:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    94,750 USD26SEC
    5,000 shares@ US$18.952.9% of flowClass A Common StockSEC:0001209191-21-012593:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    25,800 USD11SEC
    5,000 shares@ US$5.160.8% of flowClass A Common StockSEC:0001209191-21-004739:0
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    25,800 USD11SEC
    5,000 shares@ US$5.160.8% of flowClass A Common StockSEC:0001209191-21-004748:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    76,050 USD26SEC
    5,000 shares@ US$15.212.4% of flowClass A Common StockSEC:0001209191-21-004748:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    22,800 USD11SEC
    5,000 shares@ US$4.560.8% of flowClass A Common StockSEC:0001209191-20-064720:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    83,051 USD26SEC
    5,000 shares@ US$16.61022.9% of flowClass A Common StockSEC:0001209191-20-064720:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    14,478 USD11SEC
    3,175 shares@ US$4.560.5% of flowClass A Common StockSEC:0001209191-20-060913:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    48,719 USD26SEC
    3,175 shares@ US$15.34471.7% of flowClass A Common StockSEC:0001209191-20-060913:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    8,322 USD11SEC
    1,825 shares@ US$4.560.3% of flowClass A Common StockSEC:0001209191-20-059182:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    27,448 USD26SEC
    1,825 shares@ US$15.04011.0% of flowClass A Common StockSEC:0001209191-20-059182:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    20,520 USD11SEC
    4,500 shares@ US$4.560.7% of flowClass A Common StockSEC:0001209191-20-058041:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    67,963 USD26SEC
    4,500 shares@ US$15.10282.4% of flowClass A Common StockSEC:0001209191-20-058041:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    2,280 USD11SEC
    500 shares@ US$4.560.1% of flowClass A Common StockSEC:0001209191-20-055492:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    7,562 USD26SEC
    500 shares@ US$15.12380.3% of flowClass A Common StockSEC:0001209191-20-055492:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    46,840 USD11SEC
    10,272 shares@ US$4.561.8% of flowClass A Common StockSEC:0001209191-20-041123:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    159,335 USD27SEC
    7,346 shares@ US$21.696.0% of flowClass A Common StockSEC:0001209191-20-041123:1
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    64,869 USD26SEC
    2,926 shares@ US$22.172.4% of flowClass A Common StockSEC:0001209191-20-041123:2
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    68,400 USD11SEC
    15,000 shares@ US$4.562.6% of flowClass A Common StockSEC:0001209191-20-034114:0
  • ▼
    Chief Scientific OfficerExecutivesAtreca, Inc.
    275,700 USD27SEC
    15,000 shares@ US$18.3810.5% of flowClass A Common StockSEC:0001209191-20-034114:1
  • ◇
    Chief Scientific OfficerExecutivesAtreca, Inc.
    22,800 USD11SEC
    5,000 shares@ US$4.560.9% of flowClass A Common StockSEC:0001209191-20-028009:0

25 of 47 declarations